chr14-95096513-A-G

Variant names:

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_177438.3(DICER1):c.4407T>C(p.Leu1469Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000235 in 1,614,130 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00022 ( 1 hom., cov: 33)

Exomes 𝑓: 0.00024 ( 7 hom. )

Consequence

DICER1
NM_177438.3 synonymous

Scores

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.279

Publications

0 publications found

Variant links:

Genes affected

DICER1 (HGNC:17098): (dicer 1, ribonuclease III) This gene encodes a protein possessing an RNA helicase motif containing a DEXH box in its amino terminus and an RNA motif in the carboxy terminus. The encoded protein functions as a ribonuclease and is required by the RNA interference and small temporal RNA (stRNA) pathways to produce the active small RNA component that represses gene expression. This protein also acts as a strong antiviral agent with activity against RNA viruses, including the Zika and SARS-CoV-2 viruses. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2021]

DICER1 Gene-Disease associations (from GenCC):

DICER1-related tumor predisposition
Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
pleuropulmonary blastoma
Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
DICER1 syndrome
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome
Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

DICER1 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4

Computational evidence support a benign effect (REVEL=0.093).

BP6

Variant 14-95096513-A-G is Benign according to our data. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-95096513-A-G is described in CliVar as Benign/Likely_benign. Clinvar id is 261924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BP7

Synonymous conserved (PhyloP=-0.279 with no splicing effect.

BS1

Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000217 (33/152332) while in subpopulation SAS AF = 0.00621 (30/4832). AF 95% confidence interval is 0.00447. There are 1 homozygotes in GnomAd4. There are 21 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

BS2

High AC in GnomAd4 at 33 AD,Unknown gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
DICER1	NM_177438.3 link	c.4407T>C	p.Leu1469Leu	synonymous_variant	Exon 23 of 27	ENST00000343455.8	NP_803187.1	Q9UPY3-1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
DICER1	ENST00000343455.8 link	c.4407T>C	p.Leu1469Leu	synonymous_variant	Exon 23 of 27	1	NM_177438.3	ENSP00000343745.3		Q9UPY3-1

Frequencies

GnomAD3 genomes

AF:

0.000217

AC:

AN:

152214

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.0000482

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.00

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00620

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.0000147

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.000553

AC:

139

AN:

251320

AF XY:

0.000648

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.00

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.00

Gnomad OTH exome

AF:

0.000326

GnomAD4 exome

AF:

0.000237

AC:

346

AN:

1461798

Hom.:

Cov.:

AF XY:

0.000314

AC XY:

228

AN XY:

727212

show subpopulations

African (AFR)

AF:

0.0000598

AC:

AN:

33472

American (AMR)

AF:

0.00

AC:

AN:

44712

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

26136

East Asian (EAS)

AF:

0.00

AC:

AN:

39700

South Asian (SAS)

AF:

0.00371

AC:

320

AN:

86256

European-Finnish (FIN)

AF:

0.00

AC:

AN:

53416

Middle Eastern (MID)

AF:

0.000173

AC:

AN:

5768

European-Non Finnish (NFE)

AF:

8.99e-7

AC:

AN:

1111948

Other (OTH)

AF:

0.000364

AC:

AN:

60390

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.495

Heterozygous variant carriers

102

127

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Exome Hom

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.000217

AC:

AN:

152332

Hom.:

Cov.:

AF XY:

0.000282

AC XY:

AN XY:

74496

show subpopulations

African (AFR)

AF:

0.0000481

AC:

AN:

41576

American (AMR)

AF:

0.00

AC:

AN:

15306

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3470

East Asian (EAS)

AF:

0.00

AC:

AN:

5190

South Asian (SAS)

AF:

0.00621

AC:

AN:

4832

European-Finnish (FIN)

AF:

0.00

AC:

AN:

10618

Middle Eastern (MID)

AF:

0.00

AC:

AN:

294

European-Non Finnish (NFE)

AF:

0.0000147

AC:

AN:

68022

Other (OTH)

AF:

0.00

AC:

AN:

2114

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.470

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.00

Hom.:

Bravo

AF:

0.0000189

Asia WGS

AF:

0.00231

AC:

AN:

3478

ClinVar

Significance: Benign/Likely benign

Submissions summary: Benign:5

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome

Benign:2

Sep 16, 2021

Sema4, Sema4

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:curation

- -

Jun 01, 2017

Ambry Genetics

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not specified

Benign:1

Apr 11, 2016

PreventionGenetics, part of Exact Sciences

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Pleuropulmonary blastoma

Benign:1

Jul 07, 2023

KCCC/NGS Laboratory, Kuwait Cancer Control Center

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

DICER1-related tumor predisposition

Benign:1

Jan 11, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.72

CADD

Benign

0.67

(source)

DANN

Benign

0.70

PhyloP100

-0.28

Mutation Taster

=99/1

polymorphism

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over